(Q36356148)

English

Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker (English)

1 reference

Europe PubMed Central

13 August 2017

author name string

Morris DG

1

1 reference

Europe PubMed Central

13 August 2017

Pross HF

2

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

1 March 1989

1 reference

Europe PubMed Central

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

13 August 2017

169

1 reference

Europe PubMed Central

13 August 2017

3

1 reference

Europe PubMed Central

13 August 2017

717-736

1 reference

Europe PubMed Central

13 August 2017

Isolation of human NK cells by density gradient centrifugation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Antibody production by hybridomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Heterogeneity of natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine-activated killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

“NK-like” cytotoxicity of human lymphocytes cultured in media containing fetal bovine serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

High and low affinity receptors for interleukin 2: implications of pronase, phorbol ester, and cell membrane studies upon the basis for differential ligand affinities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

30 September 2017

The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

Functional studies on the precursors of human lymphokine-activated killer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

Human lymphokine-activated killer cells: further isolation and characterization of the precursor and effector cell

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189260

29 June 2018

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the precursors of the NK-like cytotoxic cells generated in the autologous mixed leukocyte reaction and by interleukin 2 activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The tissue distribution of NK-9 positive lymphoid cells including NK and AK cells and their precursors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cells: definition of a cell type rather than a function

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surface markers of human lymphokine-activated killer cells and their precursors. Analysis at the population and clonal level

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of NK cell activity against fresh human leukemia in culture with interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human T cell clones use a CD3-associated surface antigen recognition structure to exhibit both NK-like and allogeneic cytotoxic reactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of human natural cytotoxicity by IgG--I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mode of action of interferon-mediated modulation of natural killer cytotoxic activity: recruitment of pre-NK cells and enhanced kinetics of lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing the frequency of antigen-specific hybridomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody OKT-9 recognizes the receptor for transferrin on human acute lymphocytic leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2784480

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.169.3.717

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36356148&oldid=1627609382"